Hutch News

To be an oncogene or a tumor suppressor? The answer lies in the dose of p27

To be an oncogene or a tumor suppressor? The answer lies in the dose of p27

From the Kemp lab, Human Biology Division
Science Spotlight - January 15, 2018
Team awarded $4.4 million from the National Cancer Institute for pioneering immunogenic cancer research

Team awarded $4.4 million from the National Cancer Institute for pioneering immunogenic cancer research

Harnessing new technologies of high-throughput screening and large-scale public data mining to find new immunotherapy targets
News Releases - August 05, 2013